Macrophage Involvement in Systemic Sclerosis: Do We Need More Evidence?

Systems Level Analysis of Systemic Sclerosis Shows a Network of Immune and Profibrotic Pathways Connected with Genetic Polymorphisms

(2015) J. Matthew Mahoney et al.   PLoS Computational Biology

A Longitudinal Biomarker for the Extent of Skin Disease in Patients With Diffuse Cutaneous Systemic Sclerosis

(2015) Lisa M. Rice et al.   Arthritis & Rheumatology

A Hitchhiker’s Guide to Myeloid Cell Subsets: Practical Implementation of a Novel Mononuclear Phagocyte Classification System

(2015) Martin Guilliams et al.   Frontiers in Immunology

Serum CCL18 is predictive for lung disease progression and mortality in systemic sclerosis

(2014) J. Schupp et al.   EUROPEAN RESPIRATORY JOURNAL

Chronic Toll-like receptor 4 stimulation in skin induces inflammation, macrophage activation, transforming growth factor beta signature gene expression, and fibrosis

(2014) Giuseppina Stifano et al.   ARTHRITIS RESEARCH & THERAPY

Increased release of soluble CD163 by the peripheral blood mononuclear cells is associated with worse prognosis in patients with systemic sclerosis

(2013) M Bielecki et al.   Advances in Medical Sciences

Global chemokine expression in systemic sclerosis (SSc): CCL19 expression correlates with vascular inflammation in SSc skin

(2013) Allison L Mathes et al.   ANNALS OF THE RHEUMATIC DISEASES

Skin Gene Expression Correlates of Severity of Interstitial Lung Disease in Systemic Sclerosis

(2013) Shervin Assassi et al.   ARTHRITIS AND RHEUMATISM

High serum sCD163/sTWEAK ratio is associated with lower risk of digital ulcers but more severe skin disease in patients with systemic sclerosis

(2013) Otylia Kowal-Bielecka et al.   ARTHRITIS RESEARCH & THERAPY

Editorial: Molecular Insights Into Systemic Sclerosis-Associated Interstitial Lung Disease

(2013) Richard M. Silver et al.   Arthritis & Rheumatology

Association of Interferon- and Transforming Growth Factor β-Regulated Genes and Macrophage Activation With Systemic Sclerosis-Related Progressive Lung Fibrosis

(2013) Romy B. Christmann et al.   Arthritis & Rheumatology

Interspecies Comparison of Human and Murine Scleroderma Reveals IL-13 and CCL2 as Disease Subset-Specific Targets

(2012) Matthew B. Greenblatt et al.   AMERICAN JOURNAL OF PATHOLOGY

Increased serum levels of soluble CD163 in patients with scleroderma

(2012) Kazuhiro Shimizu et al.   CLINICAL RHEUMATOLOGY

Interferon and alternative activation of monocyte/macrophages in systemic sclerosis-associated pulmonary arterial hypertension

(2011) Romy B. Christmann et al.   ARTHRITIS AND RHEUMATISM

Serum CC chemokine ligand-18 predicts lung disease worsening in systemic sclerosis

(2011) K. P. Tiev et al.   EUROPEAN RESPIRATORY JOURNAL

A four-gene biomarker predicts skin disease in patients with diffuse cutaneous systemic sclerosis

(2010) G. Farina et al.   ARTHRITIS AND RHEUMATISM

Lung tissues in patients with systemic sclerosis have gene expression patterns unique to pulmonary fibrosis and pulmonary hypertension

(2010) Eileen Hsu et al.   ARTHRITIS AND RHEUMATISM

Circulating monocytes from systemic sclerosis patients with interstitial lung disease show an enhanced profibrotic phenotype

(2010) Susan K Mathai et al.   LABORATORY INVESTIGATION

Limited Systemic Sclerosis Patients with Pulmonary Arterial Hypertension Show Biomarkers of Inflammation and Vascular Injury

(2010) Sarah A. Pendergrass et al.   PLoS One

Serum levels of soluble CD163 in patients with systemic sclerosis

(2010) Wakana Nakayama et al.   RHEUMATOLOGY INTERNATIONAL

Characterization of monocyte/macrophage subsets in the skin and peripheral blood derived from patients with systemic sclerosis

(2010) Nobuyo Higashi-Kuwata et al.   ARTHRITIS RESEARCH & THERAPY

Combined analysis of monocyte and lymphocyte messenger RNA expression with serum protein profiles in patients with scleroderma

(2008) Hangjun Duan et al.   ARTHRITIS AND RHEUMATISM

Identification of candidate genes in scleroderma-related pulmonary arterial hypertension

(2008) Dmitry N. Grigoryev et al.   Translational Research

Can CCL2 serum levels be used in risk stratification or to monitor treatment response in systemic sclerosis?

(2007) M T Carulli et al.   ANNALS OF THE RHEUMATIC DISEASES

CXCL10 ( ) and CCL2 ( ) chemokines in systemic sclerosis a longitudinal study

(2007) A. Antonelli et al.   RHEUMATOLOGY